Share this
by Neoteryx Microsampling on August 15,2023
Ringwood, AUSTRALIA and Berlin, GERMANY – August 15, 2023 – Trajan Scientific and Medical is providing CE-IVD registered Mitra® devices to Fertilly, a German start-up that is now launching Europe’s first At-Home Fertility Test Kits that utilize dried blood microsampling with VAMS® technology. Fertilly’s kits are medically certified and available to consumers in Europe.
Fertilly's At-Home Fertility Kits Include Mitra Devices for Quick and Easy Finger-Stick Blood Sample Collection
The kits provide people who hope to become parents with an easy and timely way to take control of their reproductive health status in the privacy of their own home. The Mitra microsampling devices enable quick finger-stick collection of blood samples that can be sent to a lab via standard mail for analysis as dried blood.
Multiple studies have shown that dried blood Mitra samples are of a high-quality, which helps the lab generate accurate data without the need for repeat sampling and testing. Reliable samples reduce the risk of false-positive or false-negative lab test results, thus reducing unnecessary stress for people on the emotional journey to parenthood.
When a woman purchases her Fertilly At-Home Fertility Test Kit, she can follow the illustrated instructions on using the Mitra device to self-collect tiny blood samples from a finger-stick.
She mails her samples to the lab, which is more convenient than having to go into a clinic for a blood draw or to use a service that cold-ships liquid blood samples to keep them viable until they can be tested.
Fertilly’s lab analyzes the Mitra dried blood samples using state-of-the art instruments and workflows.
The test measures anti-Müllerian hormone (AMH) levels, which is used as an indicator of a woman’s ovarian reserves (the number of eggs in her ovaries).
Once lab results are available, the woman receives a personal report of her AMH level and an explanation of what this means for her fertility. Women with a higher AMH level have a higher ovarian reserve, which can increase their chances of getting pregnant naturally or through fertility treatment. Women with a lower AMH level usually have a lower ovarian reserve, which can make it harder to get pregnant.
Knowing this information enables women to investigate other factors affecting their fertility—such as age, medical history, and lifestyle—and take timely action. Fertilly customers can schedule a free consult with one of the company’s experienced patient advisors to discuss the findings and get advice on next steps.
Male partners who wish to get a complete picture of their reproductive status can purchase Fertilly’s At-Home Sperm Test Kit, which provides insight into male fertility and the quality of a man’s sperm — again, in the privacy and comfort of home. For women and men who have been frustrated by a lack of fertility information and support on the path to parenthood, Fertilly’s kits feature the most reliable tools available to provide them with answers that empower them to take more agency as they embark on their family planning journey.
“Statistics show that one in six people are affected by infertility globally, and celebrities like Jennifer Aniston have publicly discussed how emotionally devastating infertility can be, so we know this problem impacts a significant number of people. Yet, due to stigma around the issue, not enough people talk about fertility or the treatment options,” said Christoph Müller-Guntrum, Founder & CEO of Fertilly.
“We created Fertilly to fill that gap, providing accurate, timely fertility testing tools and information that support people seeking answers to their fertility questions and concerns.”
About Trajan Scientific and Medical
Trajan is a global developer and manufacturer of analytical and life sciences products and devices founded to enrich personal health through scientific tools and solutions. We aim to support science that benefits people. Trajan’s products and solutions are used in the analysis of biological, food, and environmental samples. Trajan has a portfolio and pipeline of new technologies which support the move towards decentralized personalized data-based healthcare. Trajan comprises more than 680 people with seven manufacturing sites across the US, Australia, Europe, and Malaysia, with operations in Australia, the US, Asia, and Europe. Trajan’s products and solutions are marketed under multiple product brands and services, including Neoteryx. For more information visit www.trajanscimed.com. For information on Trajan’s Neoteryx range of microsampling solutions, visit www.neoteryx.com.
About Fertilly
Fertilly accompanies women, men and couples on the path to medically assisted parenthood. The company offers patients pre-medical counselling services and patient-centered, digital processes that make the path to pregnancy much easier. Fertilly counsels future parents on finding the most suitable fertility center for each individual concern, provides a digital portal connecting patients and clinics, and provides at-home testing solutions. The company is already active in Germany, Italy and France and aims to become the leading European fertility platform. https://fertilly.com/de/
Media Contacts:
Fertilly: Christoph Müller-Guntrum, Founder and CEO, info@fertilly.com
Trajan: Amy Miller, We Communications, amymi@we-worldwide.com
Image Credits: Fertilly, Trajan, Neoteryx
No Comments Yet
Let us know what you think